AI Verdict
ABT has stronger fundamentals based on our AI analysis.
ABT vs CVS Fundamental Comparison
| Metric | ABT | CVS |
|---|---|---|
| Revenue | $11.2B | $100.4B |
| Net Income | $1.1B | $2.9B |
| Net Margin | 9.6% | 2.9% |
| ROE | 2.1% | 3.8% |
| ROA | 1.0% | 1.2% |
| Current Ratio | 1.39x | 0.87x |
| Debt/Equity | 0.57x | 0.78x |
| EPS | $0.61 | $2.30 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs CVS: Frequently Asked Questions
Is ABT or CVS the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABT has stronger fundamentals. ABT is graded B (74% confidence) while CVS is graded C (75% confidence). This is not investment advice.
How does ABT compare to CVS fundamentally?
ABBOTT LABORATORIES has ROE of 2.1% vs CVS HEALTH Corp's 3.8%. Net margins are 9.6% vs 2.9% respectively.
Which stock pays higher dividends, ABT or CVS?
ABT has a dividend yield of N/A or no dividend while CVS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or CVS for long term?
For long-term investing, consider that ABT has a B grade with 74% confidence, while CVS has a C grade with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs CVS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs CVS, the AI consensus favors ABT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.